AI assistant
MEMPHASYS LIMITED. — Capital/Financing Update 2016
Oct 12, 2016
65314_rns_2016-10-12_662b0110-f0b3-4b6c-ad5b-457003db962d.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [222 x 64] intentionally omitted <==
ASX Release
R&D TAX REFUND
Sydney, Thursday 13 October 2016
Memphasys Limited (ASX:MEM) is pleased to announce that it has received a Research and Development tax refund of $497,355.30.
Memphasys intends to apply these funds to further develop its SpermSep business and for working capital purposes.
For further information please contact:
Alison Coutts Executive Chairman +61 2 8415 7300 [email protected]
About Memphasys:
Memphasys limited (ASX:MEM) specialises in biological separations for commercial applications. The Company’s patented membrane processes enable the selection of high value substances or contaminants from the fluid in which they are contained by applying an electrical field (electrophoresis) to a sample of the fluid that is contained between our “restriction” membranes and flows through another membrane for separation.
Postal Address Contact Details E [email protected] P.O. Box 2202 P +612 8415 7300 W memphasys.com Homebush West NSW 2140 F +612 8415 7399 ABN 33 120 047 556
Memphasys Limited 30-32 Richmond Road Homebush West NSW 2140